I am Abu Siddiqui. I was born in Bangladesh and graduated in Microbiology from the University of Dhaka in 1984. I received a prestigious scholarship from the Swedish Institute to peruse my Ph.D. program in immunology in Sweden. After completion of my Ph.D. program in 1998, I moved to New York University to peruse my postdoctoral training in autoimmune disease, where I made remarkable achievements in setting up a mouse model to study the collagen-induced arthritis, an animal model for the human autoimmune disease the rheumatoid arthritis. I further received a very competitive young scientist postdoctoral fellowship from the Arthritis Foundation in 2002 to continue my investigation at Stanford University on another important autoimmune disease "Systemic Lupus Erythematosus" where I was engaged in studying the source of Interferon- in lupus mice.
I joined Merck & Co in 2004, where I served as a principal investigator and study director to investigate the immunotoxicity of biologics and vaccines. I was involved in the safety assessment of the 1st cancer vaccine GARDASIL® approved by FDA in 2006, for the prevention of cervical cancer, which is caused by the Human Papillomavirus. Presently I am working as a senior scientist in the Division of Clinical Pharmacology at Johnson & Johnson Company in Pennsylvania, overseeing the immunogenicity laboratory for non-clinica studies.
I received several international recognitions for my outstanding work in immunology. I received a best young scientist travel award from Swedish, USA, Japan, and India. My name was also published in "Who's Who International in 2000". I am a valued member of American Association for Advancement of Science, American Association of Immunologists, American Society of Cancer, American Society of Tropical Medicine and Hygiene. I published one book and many research articles in peer-reviewed journals.
I am actively involved with different charitable and social welfare organizations. I am a founder of a 250 bedded charitable hospital and medical college at Shatkhira, Bangladesh in collaboration with Bangladesh Diabetes Association which is funded by an international agency.
I am interested in researching to develop biologics and vaccine for cancer, autoimmune, and infectious diseases.
